Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

Michal Canetti; Noam Barda; Mayan Gilboa; Victoria Indenbaum; Michal Mandelboim; Tal Gonen; Keren Asraf; Yael Weiss-Ottolenghi; Sharon Amit; Ram Doolman; Ella Mendelson; Dror Harats; Laurence S. Freedman; Yitshak Kreiss; Yaniv Lustig; Gili Regev-Yochay

doi:https://doi.org/10.1038/s41467-023-37338-7

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S. Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay

Ben-Gurion University of the Negev, Tel Aviv University

Research output: Contribution to journal › Comment/debate

Abstract

The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

Original language	American English
Article number	1593
Journal	Nature Communications
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41467-023-37338-7
State	Published - 1 Dec 2023

All Science Journal Classification (ASJC) codes

General Chemistry
General Biochemistry,Genetics and Molecular Biology
General Physics and Astronomy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.1038/s41467-023-37338-7

Cite this

Canetti, M., Barda, N., Gilboa, M., Indenbaum, V., Mandelboim, M., Gonen, T., Asraf, K., Weiss-Ottolenghi, Y., Amit, S., Doolman, R., Mendelson, E., Harats, D., Freedman, L. S., Kreiss, Y., Lustig, Y., & Regev-Yochay, G. (2023). Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2). Nature Communications, 14(1), Article 1593. https://doi.org/10.1038/s41467-023-37338-7

@article{f27b454efc4a4cf9866302b731541fc3,

title = "Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)",

abstract = "The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.",

author = "Michal Canetti and Noam Barda and Mayan Gilboa and Victoria Indenbaum and Michal Mandelboim and Tal Gonen and Keren Asraf and Yael Weiss-Ottolenghi and Sharon Amit and Ram Doolman and Ella Mendelson and Dror Harats and Freedman, {Laurence S.} and Yitshak Kreiss and Yaniv Lustig and Gili Regev-Yochay",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

day = "1",

doi = "https://doi.org/10.1038/s41467-023-37338-7",

language = "American English",

volume = "14",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

Canetti, M, Barda, N, Gilboa, M, Indenbaum, V, Mandelboim, M, Gonen, T, Asraf, K, Weiss-Ottolenghi, Y, Amit, S, Doolman, R, Mendelson, E, Harats, D, Freedman, LS, Kreiss, Y, Lustig, Y & Regev-Yochay, G 2023, 'Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)', Nature Communications, vol. 14, no. 1, 1593. https://doi.org/10.1038/s41467-023-37338-7

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2). / Canetti, Michal; Barda, Noam; Gilboa, Mayan et al.
In: Nature Communications, Vol. 14, No. 1, 1593, 01.12.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Author Correction

T2 - Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

AU - Canetti, Michal

AU - Barda, Noam

AU - Gilboa, Mayan

AU - Indenbaum, Victoria

AU - Mandelboim, Michal

AU - Gonen, Tal

AU - Asraf, Keren

AU - Weiss-Ottolenghi, Yael

AU - Amit, Sharon

AU - Doolman, Ram

AU - Mendelson, Ella

AU - Harats, Dror

AU - Freedman, Laurence S.

AU - Kreiss, Yitshak

AU - Lustig, Yaniv

AU - Regev-Yochay, Gili

PY - 2023/12/1

Y1 - 2023/12/1

N2 - The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

AB - The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

UR - http://www.scopus.com/inward/record.url?scp=85150810911&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41467-023-37338-7

DO - https://doi.org/10.1038/s41467-023-37338-7

M3 - Comment/debate

C2 - 36949080

SN - 2041-1723

VL - 14

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 1593

ER -

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this